UPDATE 2-Roche to buy U.S. cancer drugmaker Ignyta for $1.7 bln

Dec 22 (Reuters) - Swiss drugmaker Roche will buy U.S. cancer drug specialist Ignyta Inc for $1.7 billion in an agreed deal to broaden its oncology portfolio, the firms said on Friday.

by support@endlesssupplies.biz (Endless Supplies .Biz) via Endless Supplies .Biz - News